123 related articles for article (PubMed ID: 20719880)
1. Factors influencing left ventricular mass regression in patients with primary aldosteronism post adrenalectomy.
Lin YH; Huang KH; Lee JK; Wang SM; Yen RF; Wu VC; Chung SD; Liu KL; Chueh SC; Lin LY; Ho YL; Chen MF; Wu KD;
J Renin Angiotensin Aldosterone Syst; 2011 Mar; 12(1):48-53. PubMed ID: 20719880
[TBL] [Abstract][Full Text] [Related]
2. The Relation Between the Degree of Left Ventricular Mass Regression and Serum Potassium Level Change in Patients With Primary Aldosteronism After Adrenalectomy.
Liao CW; Chen A; Lin YT; Chang YY; Wang SM; Wu VC; Hung CS; Wu KD; Chueh SC; Lin YH;
J Investig Med; 2015 Aug; 63(6):816-20. PubMed ID: 26083251
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.
Pan CT; Wu XM; Tsai CH; Chang YY; Chen ZW; Chang CC; Lee BC; Liao CW; Chen YL; Lin LC; Chang YR; Hung CS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():646097. PubMed ID: 33953695
[TBL] [Abstract][Full Text] [Related]
4. Cortisol Excess in Patients With Primary Aldosteronism Impacts Left Ventricular Hypertrophy.
Adolf C; Köhler A; Franke A; Lang K; Riester A; Löw A; Heinrich DA; Bidlingmaier M; Treitl M; Ladurner R; Beuschlein F; Arlt W; Reincke M
J Clin Endocrinol Metab; 2018 Dec; 103(12):4543-4552. PubMed ID: 30113683
[TBL] [Abstract][Full Text] [Related]
5. Reversal of myocardial fibrosis in patients with unilateral hyperaldosteronism receiving adrenalectomy.
Lin YH; Lee HH; Liu KL; Lee JK; Shih SR; Chueh SC; Lin WC; Lin LC; Lin LY; Chung SD; Wu VC; Kuo CC; Ho YL; Chen MF; Wu KD;
Surgery; 2011 Sep; 150(3):526-33. PubMed ID: 21514614
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of adrenalectomy or spironolactone on blood pressure control and regression of left ventricle hypertrophy in patients with primary aldosteronism.
Indra T; Holaj R; Štrauch B; Rosa J; Petrák O; Šomlóová Z; Widimský J
J Renin Angiotensin Aldosterone Syst; 2015 Dec; 16(4):1109-17. PubMed ID: 25271250
[TBL] [Abstract][Full Text] [Related]
7. Adrenalectomy reverses myocardial fibrosis in patients with primary aldosteronism.
Lin YH; Wu XM; Lee HH; Lee JK; Liu YC; Chang HW; Lin CY; Wu VC; Chueh SC; Lin LC; Lo MT; Ho YL; Wu KD;
J Hypertens; 2012 Aug; 30(8):1606-13. PubMed ID: 22688266
[TBL] [Abstract][Full Text] [Related]
8. [Left ventricular myocardial structure and function in patients with primary aldosteronism].
Arabidze GG; Chikhladze NM; Sergakova LM; Iarovaia EB
Ter Arkh; 1999; 71(9):13-9. PubMed ID: 10553618
[TBL] [Abstract][Full Text] [Related]
9. Regression of left ventricular hypertrophy in patients with primary aldosteronism/low-renin hypertension on low-dose spironolactone.
Ori Y; Chagnac A; Korzets A; Zingerman B; Herman-Edelstein M; Bergman M; Gafter U; Salman H
Nephrol Dial Transplant; 2013 Jul; 28(7):1787-93. PubMed ID: 23378418
[TBL] [Abstract][Full Text] [Related]
10. Nadir Aldosterone Levels After Confirmatory Tests Are Correlated With Left Ventricular Hypertrophy in Primary Aldosteronism.
Ohno Y; Sone M; Inagaki N; Kawashima A; Takeda Y; Yoneda T; Kurihara I; Itoh H; Tsuiki M; Ichijo T; Katabami T; Wada N; Sakamoto R; Ogawa Y; Yoshimoto T; Yamada T; Kawashima J; Matsuda Y; Kobayashi H; Kamemura K; Yamamoto K; Otsuki M; Okamura S; Izawa S; Okamoto R; Tamura K; Tanabe A; Naruse M;
Hypertension; 2020 Jun; 75(6):1475-1482. PubMed ID: 32248705
[TBL] [Abstract][Full Text] [Related]
11. Renin, a marker for left ventricular hypertrophy, in primary aldosteronism: a cohort study.
Köhler A; Sarkis AL; Heinrich DA; Müller L; Handgriff L; Deniz S; Schneider H; Künzel H; Ladurner R; Reincke M; Adolf C
Eur J Endocrinol; 2021 Oct; 185(5):663-672. PubMed ID: 34468397
[TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism.
Hung CS; Ho YL; Chang YY; Wu VC; Wu XM; Lee JK; Chueh SC; Lin YH; Changh YS; Yang SY; Hu YH; Sui MJ; Chen MF; Wu KD
ScientificWorldJournal; 2013; 2013():294594. PubMed ID: 24459427
[TBL] [Abstract][Full Text] [Related]
13. The association of serum potassium level with left ventricular mass in patients with primary aldosteronism.
Lin YH; Wang SM; Wu VC; Lee JK; Kuo CC; Yen RF; Liu KL; Huang KH; Chueh SC; Wang WJ; Lin LY; Chien KL; Ho YL; Chen MF; Wu KD;
Eur J Clin Invest; 2011 Jul; 41(7):743-50. PubMed ID: 21250985
[TBL] [Abstract][Full Text] [Related]
14. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
[TBL] [Abstract][Full Text] [Related]
15. Predictive factors of left ventricular mass changes after treatment of primary aldosteronism.
Catena C; Colussi GL; Marzano L; Sechi LA
Horm Metab Res; 2012 Mar; 44(3):188-93. PubMed ID: 22351477
[TBL] [Abstract][Full Text] [Related]
16. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
17.
Chang YY; Tsai CH; Peng SY; Chen ZW; Chang CC; Lee BC; Liao CW; Pan CT; Chen YL; Lin LC; Chang YR; Peng KY; Chou CH; Wu VC; Hung CS; Lin YH;
Hypertension; 2021 Jan; 77(1):114-125. PubMed ID: 33249859
[TBL] [Abstract][Full Text] [Related]
18. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
[TBL] [Abstract][Full Text] [Related]
19. Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.
Cuspidi C; Tadic M; Sala C; Quarti-Trevano F; Gherbesi E; Mancia G; Grassi G
J Hypertens; 2021 Apr; 39(4):775-783. PubMed ID: 33044383
[TBL] [Abstract][Full Text] [Related]
20. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
